Pharvaris N.V. (PHVS)

Pharvaris Income Statement

Financials in millions EUR. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	33.81	31.34	29.34	18.35	5.5	2.33
Research & Development	70.34	65.58	57.38	35.79	19.51	5.68
Operating Expenses	104.15	96.91	86.71	54.14	25.01	8.01
Operating Income	-104.15	-96.91	-86.71	-54.14	-25.01	-8.01
Interest Expense / Income	0.84	2.91	-11.06	-11.48	1.06	0.02
Pretax Income	-104.99	-99.83	-75.65	-42.66	-26.07	-8.03
Income Tax	1.27	1.05	0.68	0.07	-0.08	0
Net Income	-106.26	-100.88	-76.33	-42.73	-25.99	-8.03
Shares Outstanding (Basic)	41	41	34	33	31	31
Shares Change	21.30%	21.30%	1.99%	8.55%	-	-
EPS (Basic)	-2.49	-2.63	-2.27	-1.40	-5.36	-1.66
EPS (Diluted)	-2.49	-2.63	-2.27	-1.40	-5.36	-1.66
Free Cash Flow	-92.18	-93.14	-67.29	-44.73	-21.54	-6.69
Free Cash Flow Per Share	-2.25	-2.27	-1.99	-1.35	-0.71	-0.22
EBITDA	-103.89	-96.66	-86.56	-54.06	-25	-8.01
Depreciation & Amortization	0.26	0.26	0.15	0.08	0.01	0
EBIT	-104.15	-96.91	-86.71	-54.14	-25.01	-8.01

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).